Assessing the reproducibility of the SienaX and Siena brain atrophy measures using the ADNI back-to-back MP-RAGE MRI scans.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Psychiatry Research

• Publication date

  2011-09-30

• Fields of study

  Medicine, Computer Science, Psychology

• Identifiers
  DOI 10.1016/j.pscychresns.2011.02.012PMID 21764565
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gradient distortions in MRI: Characterizing and correcting for their effects on SIENA-generated measures of brain volume change

  2010cited by this paper
• Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study.

  2010cited by this paper
• Corrigendum to "Gradient distortions in MRI: Characterizing and correcting for their effects on SIENA-generated measures of brain volume change" [NeuroImage 49 (2010) 1601-1611]

  2010cited by this paper
• Impact of scanner hardware and imaging protocol on image quality and compartment volume precision in the ADNI cohort

  2010cited by this paper
• Comparison of AdaBoost and Support Vector Machines for Detecting Alzheimer's Disease Through Automated Hippocampal Segmentation

  2010cited by this paper
• The clinical use of structural MRI in Alzheimer disease

  2010cited by this paper
• Volume changes in Alzheimer’s disease and mild cognitive impairment: cognitive associations

  2010influential reference
• Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis

  2009influential reference
• Imaging outcomes for neuroprotection and repair in multiple sclerosis trials

  2009cited by this paper
• Measurement of MRI scanner performance with the ADNI phantom.

  2009cited by this paper
• Evaluation of automated brain MR image segmentation and volumetry methods

  2009cited by this paper
• Fully automatic hippocampus segmentation and classification in Alzheimer's disease and mild cognitive impairment applied on data from ADNI

  2009cited by this paper
• Comparison of phantom and registration scaling corrections using the ADNI cohort

  2009cited by this paper
• Accelerating regional atrophy rates in the progression from normal aging to Alzheimer’s disease

  2009cited by this paper
• Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?

  2009cited by this paper
• Subregional neuroanatomical change as a biomarker for Alzheimer's disease

  2009influential reference
• Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls

  2008cited by this paper
• The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods

  2008cited by this paper
• Whole-brain atrophy rate in Alzheimer disease

  2008influential reference
• Enhanced brain extraction improves the accuracy of brain atrophy estimation

  2008cited by this paper
• Agreement between different input image types in brain atrophy measurement in multiple sclerosis using SIENAX and SIENA

  2008cited by this paper
• Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually‐edited SIENA and SIENAX

  2007cited by this paper
• Measuring Brain Atrophy in Multiple Sclerosis

  2007cited by this paper
• Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: Cross-validation of BSI, SIENA and SIENAX

  2007influential reference
• The measurement and clinical relevance of brain atrophy in multiple sclerosis.

  2006cited by this paper
• Combining short interval MRI in Alzheimer’s disease

  2006cited by this paper
• Reproducibility and Accuracy of Quantitative Magnetic Resonance Imaging Techniques of Whole‐Brain Atrophy Measurement in Multiple Sclerosis

  2005cited by this paper
• Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis

  2004cited by this paper
• Whole-brain atrophy in multiple sclerosis measured by two segmentation processes from various MRI sequences.

  2003cited by this paper
• Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis

  2002influential reference
• Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance.

  2002cited by this paper
• Fast robust automated brain extraction

  2002cited by this paper
• Neurotechnique Whole Brain Segmentation: Automated Labeling of Neuroanatomical Structures in the Human Brain

  2002cited by this paper
• Normalized Accurate Measurement of Longitudinal Brain Change

  2001cited by this paper
• Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease

  2000cited by this paper
• Voxel-based morphometry--the methods.

  2000cited by this paper
• Progressive cerebral atrophy in MS

  2000cited by this paper
• The effect of interferon beta-1 b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis

  2000cited by this paper
• The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.

  2000cited by this paper
• Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS

  1999cited by this paper
• Correlation between rates of brain atrophy and cognitive decline in AD

  1999influential reference
• Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

  1999cited by this paper
• Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease

  1998cited by this paper
• The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI

  1997cited by this paper
• Visualisation and quantification of rates of atrophy in Alzheimer's disease.

  1996cited by this paper
• Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study.

  1996cited by this paper
• Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.

  1996cited by this paper
• Bootstrapping: A Nonparametric Approach to Statistical Inference

  1993cited by this paper
• Three‐dimensional magnetization‐prepared rapid gradient‐echo imaging (3D MP RAGE)

  1990cited by this paper
• Practical statistics for medical research

  1990cited by this paper

• Correlation of early-phase β-amyloid positron-emission-tomography and neuropsychological testing in patients with Alzheimer’s disease

  2025cites this paper
• Radiological Reporting of Brain Atrophy in MRI: Real-Life Comparison Between Narrative Reports, Semiquantitative Scales and Automated Software-Based Volumetry

  2025cites this paper
• Clinical validation of artificial intelligence-based single-subject morphometry without normative reference database

  2025cites this paper
• Removing outliers from the normative database improves regional atrophy detection in single-subject voxel-based morphometry

  2024cites this paper
• Voxel-based morphometry in single subjects without a scanner-specific normal database using a convolutional neural network

  2023cites this paper
• Automatic segmentation of the thalamus using a massively trained 3D convolutional neural network: higher sensitivity for the detection of reduced thalamus volume by improved inter-scanner stability

  2022cites this paper
• Generating Longitudinal Atrophy Evaluation Datasets on Brain Magnetic Resonance Images Using Convolutional Neural Networks and Segmentation Priors

  2021cites this paper
• Novel multi-linear quantitative brain volume formula for manual radiological evaluation of brain atrophy

  2020cites this paper
• Evaluating the Effect of Intensity Standardisation on Longitudinal Whole Brain Atrophy Quantification in Brain Magnetic Resonance Imaging

  2020cites this paper
• Brain volume loss in individuals over time: Source of variance and limits of detectability

  2020cites this paper
• Role of Mind Diet in Preventing Dementia and Alzheimers Disease

  2020cites this paper
• Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia

  2019cites this paper
• Applications of Neuroimaging Biomarkers in CNS Drug Development

  2019cites this paper
• Novel imaging phantom for accurate and robust measurement of brain atrophy rates using clinical MRI

  2019cites this paper
• Early imaging predictors of longer term multiple sclerosis risk and severity in acute optic neuritis

  2019cites this paper
• SIENA‐XL for improving the assessment of gray and white matter volume changes on brain MRI

  2018cites this paper
• A decade of changes in brain volume and cognition

  2018cites this paper
• Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI

  2018influential citation
• Reproducibility of Deep Gray Matter Atrophy Rate Measurement in a Large Multicenter Dataset

  2018cites this paper
• Assessing Biological and Methodological Aspects of Brain Volume Loss in Multiple Sclerosis

  2018cites this paper
• The Role of Nutrition in Cognitive Function and Brain Ageing in the Elderly

  2018cites this paper
• Automatic normative quantification of brain tissue volume to support the diagnosis of dementia: A clinical evaluation of diagnostic accuracy

  2018cites this paper
• Can measuring hippocampal atrophy with a fully automatic method be substantially less noisy than manual segmentation over both 1 and 3 years?

  2018cites this paper
• Estimates of age-dependent cutoffs for pathological brain volume loss using SIENA/FSL-a longitudinal brain volumetry study in healthy adults.

  2017cites this paper
• Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease

  2016cites this paper
• Reliable measurements of brain atrophy in individual patients with multiple sclerosis

  2016cites this paper
• Reproducibility of hippocampal atrophy rates measured with manual, FreeSurfer, AdaBoost, FSL/FIRST and the MAPS-HBSI methods in Alzheimer's disease.

  2016influential citation
• Atlas based brain volumetry: How to distinguish regional volume changes due to biological or physiological effects from inherent noise of the methodology.

  2016cites this paper
• Brain parenchymal fraction in healthy individuals and in clinical follow-up of multiple sclerosis

  2016cites this paper
• Identifying Associations between Vascular Risk Factors and Measures of Brain Health using Multimodal Magnetic Resonance Imaging

  2016cites this paper
• Correlation between hippocampal sulcus width and severity of obstructive sleep apnea syndrome

  2015cites this paper
• 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

  2015cites this paper
• Novel composite MRI scale correlates highly with disability in multiple sclerosis patients.

  2015cites this paper
• Longitudinal assessment of global and regional atrophy rates in Alzheimer's disease and dementia with Lewy bodies

  2015cites this paper
• Volume of hippocampal substructures in borderline personality disorder.

  2015cites this paper
• Empowering imaging biomarkers of Alzheimer's disease.

  2015cites this paper
• Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's disease

  2015cites this paper
• Validation of the automated method VIENA: An accurate, precise, and robust measure of ventricular enlargement

  2014cites this paper
• Hippocampal volume change measurement: Quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST

  2014cites this paper
• Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosis.

  2014cites this paper
• Dysglycemia, brain volume and vascular lesions on MRI in a memory clinic population.

  2014cites this paper
• A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative.

  2014cites this paper
• Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions

  2014cites this paper
• The SIENA/FSL whole brain atrophy algorithm is no more reproducible at 3T than 1.5 T for Alzheimer's disease.

  2014influential citation
• Improved longitudinal gray and white matter atrophy assessment via application of a 4-dimensional hidden Markov random field model

  2014influential citation
• Maximizing power to track Alzheimer's disease and MCI progression by LDA-based weighting of longitudinal ventricular surface features

  2013cites this paper
• Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criteria for Alzheimer ’ s disease

  2013cites this paper
• Shape Analysis Methods for 3D Brain and Skull Imaging

  2013cites this paper
• MRI- and PET-Based Imaging Markers for the Diagnosis of Alzheimer’s Disease

  2012cites this paper
• The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

  2012cites this paper
• Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis

  2012cites this paper
• Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease

  2011cites this paper
• High-dimensional morphometry Empowering imaging biomarkers of Alzheimer ’ s disease

  year unknowncites this paper